United Kingdom Pet Blood Pressure Monitoring Device Market Size & Outlook, 2026-2034
United Kingdom Pet Blood Pressure Monitoring Device Market Insights
- As highlighted in Reed Intelligence analysis, the United Kingdom Pet Blood Pressure Monitoring Device Market, worth USD 8.55 Million in 2025, is forecasted to achieve USD 18.05 Million by 2034.
- The United Kingdom market is anticipated to grow at a CAGR of 8.61% during the period 2026–2034.
- By 2025, Doppler Blood Pressure Monitors represented the largest share of the Product Type market size.
- Doppler Blood Pressure Monitors is expected to remain the key growth driver within Product Type, registering the fastest CAGR during the forecast period.
Source: RI Analysis Company Publications, Primary Interviews.
Other Key Findings
- United Kingdom contributed 4.03% to the global Pet Blood Pressure Monitoring Device Market size in 2025.
- By 2034, United States is forecasted to remain the largest global market for Pet Blood Pressure Monitoring Device Market.
- In Europe, Germany is projected to capture the leading share of market size by 2034.
- Among Europe markets, Italy is expected to post the fastest growth, reaching USD 9.88 Million by 2034.
Report Summary
| Report Scope | Details |
|---|---|
| Base Year for Study | 2025 |
| Study Period | 2022-2034 |
| Historical Period | 2022-2024 |
| Forecast Period | 2026-2034 |
| Market Size In 2025 | USD 8.55 Million |
| Market Size In 2034 | USD 18.05 Million |
| Largest segment | Doppler Blood Pressure Monitors |
| Units | Revenue in USD Million |
| CAGR | 8.61% (2026-2034) |
| Segmnetation Covered | |
| Product Type |
|
| Animal Type |
|
| End Use |
|
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends |
United Kingdom Pet Blood Pressure Monitoring Device Market Product Type 2026-2034 (USD Million)
| Product Type | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Doppler Blood Pressure Monitors | XX.x | XX.x | XX.x | 4.05 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Oscillometric Blood Pressure Monitors | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Wearable and Remote Monitoring Devices | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: RI Analysis Company Publications, Primary Interviews.
United Kingdom Pet Blood Pressure Monitoring Device Market Animal Type 2026-2034 (USD Million)
| Animal Type | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dogs | XX.x | XX.x | XX.x | 3.91 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Cats | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Other Companion Animals | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: RI Analysis Company Publications, Primary Interviews.
United Kingdom Pet Blood Pressure Monitoring Device Market End Use 2026-2034 (USD Million)
| End Use | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Veterinary Hospitals | XX.x | XX.x | XX.x | 3.47 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Veterinary Clinics | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Veterinary Diagnostic Laboratories | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Research Institutions | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: RI Analysis Company Publications, Primary Interviews.
